1mg Mobile App

Tata 1mg now holds 31% of the market share, up from 19% in October 2022. PharmEasy's market share decreased to 15% from 33% in the same period

Since Tata 1mg is focused on online diagnostics and home collection of samples, it has third-party partners for radiology tests

The company runs a mobile app, '1mg', with a little over 9 mn downloads